Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
Investors 3
| Date | Name | Website |
| 05.07.2024 | Pax Moment... | paxmv.com |
| - | Pax Moment... | paxmv.vc |
| 30.11.2024 | Swan Ventu... | swanventur... |
Mentions in press and media 3
| Date | Title | Description |
| 18.08.2025 | ViewsML and iProcess Announce Strategic Partnership to Accelerate Delivery of AI-Powered Virtual Biomarker Testing | ViewsML Technologies iProcess Global Research Partnership brings ViewsML’s virtual IHC platform to iProcess customers - enabling faster, tissue-sparing biomarker testing We’re excited to partner with iProcess to bring the benefits of our vi... |
| 17.06.2025 | ViewsML and Debiopharm Collaborate to Advance Virtual Biomarker Technology in Drug Research | ViewsML Technologies Debiopharm Debiopharm taps ViewsML’s AI-driven platform to streamline biomarker detection in oncology research. Working with ViewsML allows us to integrate advanced AI solutions into our biomarker research, optimizing o... |
| 08.04.2025 | ViewsML and Dartmouth Health Partner to Advance AI-Driven Virtual Biomarkers and Diagnostics | ViewsML Technologies Dartmouth Hitchcock Medical Center ViewsML's AI technology joins Dartmouth Health's clinical expertise to create virtual biomarkers that transform pathology diagnostics ViewsML's transformative AI platform represents a ... |